the result of the group study on adjuvant chemotherapy with hd-mtx , adr and cpm for 25 cases of osteosarcomas is as follows : overall survival at three and a half years is 58.4 % and the disease-free survival is 40 % .
C0025677
mtx
C0029463
osteosarcomas